Raphaël Brunschvig

Business Development Manager at Petal

Raphaël Brunschvig has diverse work experience in various roles and industries. Raphaël currently holds the position of Institutional Partnerships & Business Development Manager (Europe) at Petal since March 2023. Before that, they worked as a Key Account Manager DACH/Central Europe at Chronolife, a healthcare AI company specializing in remote monitoring and prediction of patient health status, from April 2021 to December 2022.

Prior to that, Raphaël served as a Customer Success & Business Development Manager at The_Hacking_Project, an organization focused on peer-to-peer education and collective knowledge sharing, from November 2020 to June 2021. Raphaël also worked as a People & Change Management Consultant at KPMG France from January 2019 to July 2019.

Raphaël has gained experience in the field of research as well, serving as a Mindfulness Based Stress Reduction (MBSR) Program Research Associate at Manpower from September 2018 to December 2018. Raphaël also worked as an HR Business Partner at Movinga in October and December 2017.

In addition, Raphaël had an early professional experience as a Trainee at Shire from July 2017 to October 2017.

Raphaël Brunschvig's education history begins in 2011 when they enrolled at Lycée Pierre De Fermat and pursued a Scientific Baccalaureate with a focus on Maths, Physics, and Chemistry. Raphaël successfully completed their studies in 2014.

Following this, Raphaël attended Lycée Pierre De Fermat from 2014 to 2016, where they completed a Preparatory Class with a field of study in Economics and Statistics.

In 2016, Raphaël Brunschvig enrolled at emlyon business school, where they pursued an MSc in Management from 2016 to 2021. During their time at emlyon business school, they also had the opportunity to participate in an exchange semester at Maastricht University School of Business and Economics in 2020.

Apart from their formal education, Raphaël has obtained certifications in Drug Commercialization, Drug Development, and Drug Discovery, which were received from UC San Diego in April 2021.

Links

Previous companies

Chronolife logo

Timeline

  • Business Development Manager

    March, 2023 - present